Original site: www.cdc.gov/rsvvaxview/dashboard/2023-24-pregnant-persons-coverage.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.

[More]
About Us Report Bug

RestoredCDC.org Comparison

Removed: Line removed from cdc.gov. Specific word removals are highlighted.
Added: Line added to cdc.gov. Specific word additions are highlighted.
Injected: Line or disclaimer added by RestoredCDC.org.
Unchanged: Line unchanged.
Original site: www.cdc.gov/rsvvaxview/dashboard/2023-24-pregnant-persons-coverage.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.
[More]
About Us Report Bug Compare Content
Skip directly to site content Skip directly to search
An official website of the United States government
Here's how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.
RSVVaxView
Explore Topics
Search
Search
Clear Input
For Everyone
* Publications
* Weekly RSV Vaccination Dashboard
* View all
View All
search close search
search
RSVVaxView Menu Close
RSVVaxView Menu
search
For Everyone
* Publications
* Weekly RSV Vaccination Dashboard
* View All Home
View All RSVVaxView
Publications Weekly RSV Vaccination Dashboard View All
September 25, 2024
2023-24 Respiratory Syncytial Virus (RSV) Vaccination Coverage, Pregnant Persons
2023-24 Respiratory Syncytial Virus (RSV) Vaccination Coverage, Pregnant Women
At a glance
These weekly RSV vaccination coverage estimates for pregnant persons 18─49 years are based on electronic health record data from the Vaccine Safety Datalink.
These weekly RSV vaccination coverage estimates for pregnant Women 18─49 years are based on electronic health record data from the Vaccine Safety Datalink.
RSV Vaccination Coverage, Pregnant Persons
RSV Vaccination Coverage, Pregnant Women
* These weekly RSV vaccination coverage estimates for pregnant persons 18–49 years are based on electronic health record (EHR) data from the Vaccine Safety Datalink (VSD), a collaboration between CDC's Immunization Safety Office and multiple integrated health care organizations.*
* These weekly RSV vaccination coverage estimates for pregnant women 18–49 years are based on electronic health record (EHR) data from the Vaccine Safety Datalink (VSD), a collaboration between CDC's Immunization Safety Office and multiple integrated health care organizations.*
* The denominator includes those who reached at least 32 weeks gestation since September 22, 2023. Denominator may also include pregnant persons who were past the recommended window of 32-36 weeks gestation prior to September 22, 2023. Pregnant persons are not removed from the numerator or denominator when the pregnancy ends.
* The denominator includes those who reached at least 32 weeks gestation since September 22, 2023. Denominator may also include pregnant women who were past the recommended window of 32-36 weeks gestation prior to September 22, 2023. Pregnant women are not removed from the numerator or denominator when the pregnancy ends.
* The numerator includes those who have received an RSV vaccine as of the week ending date.
* Implementation timelines and availability of RSV vaccine differed across participating VSD sites; therefore, early coverage estimates may include persons in the denominator who were not able to receive vaccination starting September 22, 2023, when the vaccine was first recommended. By November 25, 2023, all VSD sites were offering RSV vaccination to pregnant persons.
* Implementation timelines and availability of RSV vaccine differed across participating VSD sites; therefore, early coverage estimates may include women in the denominator who were not able to receive vaccination starting September 22, 2023, when the vaccine was first recommended. By November 25, 2023, all VSD sites were offering RSV vaccination to pregnant women.
* Figure 5. Percent of pregnant persons ages 18-49 years vaccinated† with RSV vaccine overall and by race and ethnicity – Vaccine Safety Datalink
* Figure 5. Percent of pregnant women ages 18-49 years vaccinated† with RSV vaccine overall and by race and ethnicity – Vaccine Safety Datalink
View and Download Data for Fig. 5
*Naleway AL, Crane B, Irving SA, Bachman D, Vesco KK, Daley MF, Getahun D, Glenn SC, Hambidge SJ, Jackson LA, Klein NP, McCarthy NL, McClure DL, Panagiotakopoulos L, Panozzo CA, Vazquez-Benitez G, Weintraub ES, Zerbo O, Kharbanda EO. Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination. Ther Adv Drug Saf. 2021 Jun 14;12:20420986211021233. doi: 10.1177/20420986211021233. PMID: 34178302; PMCID: PMC8207278.
†Vaccinations may have been administered outside the recommended window of 32-36 weeks gestation. Frequently Asked Questions About RSV Vaccine for Pregnant People | CDC
†Vaccinations may have been administered outside the recommended window of 32-36 weeks gestation. Frequently Asked Questions About RSV Vaccine for Pregnant Women | CDC
Related Pages
View All
Back to Top
* Weekly RSV Vaccination Dashboard
* 2023-24 Jurisdiction Vaccine Administration
* 2023-24 Adults 65+ Coverage
* 2023-24 Adult Vaccinations Administered
* 2023-24 Nirsevimab Coverage
* 2023-24 Nirsevimab Administration & Coverage by Jurisdiction
View All RSVVaxView
2023-24 Nirsevimab Coverage
September 25, 2024
Sources Print Share
Facebook LinkedIn Twitter Syndicate
Content Source:
National Center for Immunization and Respiratory Diseases
Related Pages
View All
 
* Weekly RSV Vaccination Dashboard
* 2023-24 Jurisdiction Vaccine Administration
* 2023-24 Adults 65+ Coverage
* 2023-24 Adult Vaccinations Administered
* 2023-24 Nirsevimab Coverage
* 2023-24 Nirsevimab Administration & Coverage by Jurisdiction
View All RSVVaxView
Back to Top
RSVVaxView
Learn more about surveys used to measure RSV vaccination coverage, their results, and other issues relating to RSV vaccination.
View All
* Publications
* Weekly RSV Vaccination Dashboard
Sign up for Email Updates
Contact Us
Contact Us
* Call 800-232-4636
* Contact CDC
About CDC
About CDC
* Pressroom
* Organization
* Budget & Funding
* Careers & Jobs
Policies
* Accessibility
* External Links
* Privacy
* Web Policies
* FOIA
* OIG
* No Fear Act
* Nondiscrimination
* Vulnerability Disclosure Policy
Languages
Languages
* Español
Language Assistance
* Español
* 繁體中文
* Tiếng Việt
* 한국어
* Tagalog
* Русский
* العربية
* Kreyòl Ayisyen
* Français
* Polski
* Português
* Italiano
* Deutsch
* 日本語
* فارسی
* English
Archive
* CDC Archive
* Public Health Publications
Contact Us
Contact Us
* Call 800-232-4636
* Contact CDC
About CDC
* Pressroom
* Organization
* Budget & Funding
* Careers & Jobs
* About CDC
Policies
* Accessibility
* External Links
* Privacy
* Web Policies
* FOIA
* OIG
* No Fear Act
* Nondiscrimination
* Vulnerability Disclosure Policy
Languages
Languages
* Español
Language Assistance
* Español
* 繁體中文
* Tiếng Việt
* 한국어
* Tagalog
* Русский
* العربية
* Kreyòl Ayisyen
* Français
* Polski
* Português
* Italiano
* Deutsch
* 日本語
* فارسی
* English
Archive
* CDC Archive
* Public Health Publications
HHS.gov USA.gov
Note: Comparison ignores leading/trailing whitespace and certain script/tracking codes. Word-level highlighting (optional above) only applies to changed lines.